Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies
Publication

Publications

Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies

Title
Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies
Type
Another Publication in an International Scientific Journal
Year
2012
Authors
de Mello, RA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Costa, BM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Reis, RM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Journal
Vol. 7 No. 1
Pages: 118-131
ISSN: 1574-8928
Publisher: Bentham Science
Other information
Authenticus ID: P-002-GHD
Abstract (EN): Lung cancer is a highly prevalent disease worldwide. Currently, there are more than 150 million patients with lung cancer in the world, with more than 1 million new cases diagnosed per year. Tumoral angiogenesis is an important hallmark of this disease, but despite being extensively studied, the complete angiogenic mechanisms are not fully elucidated. Recent studies have reported a correlation between pharmacological inhibition of these angiogenic mechanisms and improvement of overall survival in lung cancer patients, mainly for those in advanced stages. The family of vascular endothelial growth factor (VEGF) proteins has critical roles in tumoral angiogenesis. An interaction between VEGF-A and VEGF receptor 2 (VEGFR-2) is the main pathway of activation and maintenance of angiogenesis. In tumors, this process is intimately correlative with progression and metastasis. Some studies suggested that serum levels of VEGF are higher in patients with lung cancer, especially in some types of non-small cell lung cancer (NSCLC). Other studies revealed that genetic polymorphisms of VEGF correlate with susceptibility, prognosis, and therapeutic response of some patients with NSCLC. This paper aims to review the impact of angiogenesis, especially on VEGF pathways, in NSCLC, and highlights the relevance of known and new patents disclosed of anti-angiogenic therapies in these patients.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 14
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Association between EGF+61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study (2012)
Article in International Scientific Journal
de Mello, RA; Ferreira, M; Costa, S; Costa, BM; Pires, FS; Neves, I; Almeida, MI; Cunha, J; oliveira, p; Hespanhol V; Reis, RM

Of the same journal

Ribonucleotide reductase: A critical enzyme for cancer chemotherapy and antiviral agents (2007)
Another Publication in an International Scientific Journal
Nuno M F S A Cerqueira; Pedro A Fernandes; Maria J Ramos
Recent Patents on Proteasome Inhibitors of Natural Origin (2017)
Another Publication in an International Scientific Journal
da Silva, DC; Paula B Andrade; Ribeiro, V; Patricia Valentao; David M Pereira
Modulation of Proteostasis and Proteolytic Pathways as an Anti-Cancer Strategy (2017)
Another Publication in an International Scientific Journal
David M Pereira
Aryl- and Heteroaryl-Thiosemicarbazone Derivatives and Their Metal Complexes: A Pharmacological Template (2013)
Another Publication in an International Scientific Journal
Narayana S H N Moorthy; Nuno M F S A Cerqueira; Maria J Ramos; Pedro A Fernandes
Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies. (2012)
Article in International Scientific Journal
Ramon Andrade de Mello; Bruno Marques Costa; Rui Manuel Reis; Venceslau Hespanhol

See all (6)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-08 at 06:36:50 | Privacy Policy | Personal Data Protection Policy | Whistleblowing